Latus Therapeutics Limited, founded in 2019, is a leading research and experimental development biotech company with a vision to find a cure for cancer. We are specifically looking at the B-cell Lymphomas in order to get a better understanding of the underlying signalling mechanism of the cell and its potential in helping people to combat cancer.

Today, in response to the public health crisis, Latus Therapeutics has refocused its efforts to originate not for profit initiative to find a treatment for the patients tested positive with the COVID-19.  At a time when thousands of people around the world are dying every day from the disease and economies are paralysed, this crucial research will utilise existing medicines that have already been shown to prevent the virus from infecting human cells in vitro. More information about the trials can be found on our website. Latus' team is contributing their time for free.

Nafamostat to be evaluated as a potential treatment for COVID-19

We are excited to announce the commencement of trials with Nafamostat that is proven to be the most potent antiviral drug candidate


Research & Development 


Clinical Trials



New drugs could halt spread of killer coronavirus | Express, April 26, 2020
  • LinkedIn

Founder - SPIKE trials

Managing Director of the 

Latus Therapeutics

Dr. Suzie Anthony

  • LinkedIn

Clinical Advisor - SPIKE trials

Honorary Senior Clinical Lecturer in Radiology, 

Oxford University Hospital

  • LinkedIn

Scientific Lead - SPIKE trials

Department of Pharmacology, 

University of Oxford

Prof. Graham Richards, CBE FRS FRSC Chem

  • LinkedIn

Scientific Advisor - SPIKE trials

Chairman of Oxford Drug Design

Founder of Oxford University Innovation

Ex-Head of Chemistry Department, 

University of Oxford

  • LinkedIn

Trial coordinator - SPIKE trials

Consultant Radiologist

Oxford University Hospital

  • LinkedIn

Clinical Advisor - SPIKE trials

Academic Clinical Fellow, Primary Care,

Oxford University

Bobojon Nazarov

Contact us


© 2020 Latus Therapeutics